Clinical Trial Update: Evaluation of the PS100B for the Diagnostic of Stroke With Patients Out of Delay for Thrombolysis or Thrombectomy

View source ↗

Summary

A clinical trial evaluating the diagnostic use of the PS100B biomarker for stroke in patients outside the treatment window has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Poitiers University Hospital | Conditions: Stroke | Status: COMPLETED